Y arthritis. J. Clin. Invest. 105:1799806. 34. Wei, X.Q., Leung, B.P., Arthur, H.M., McInnes, I.B., and Liew, F. Y. 2001. Reduced incidence and severity of collagen-induced Interferon & Receptors Proteins Storage & Stability arthritis in mice lacking IL-18. J. Immunol. 166:51721. 35. Leung, B.P., McInnes, I.B., Esfandiari, E., Wei, X.Q., and Liew, F. Y. 2000. Combined effects of IL-12 and IL-18 on the induction of collageninduced arthritis. J. Immunol. 164:6495502. 36. Leung, B.P., et al. 2000. Interleukin-18 can promote synovial inflammation through activation of peripheral blood and synovial neutrophils. Arthritis Rheum. 43:1253.The Journal of Clinical InvestigationDecemberVolumeNumber
Articular cartilage is definitely the load-bearing material of diarthrodial joints, with excellent friction, lubrication, and wear-resistance traits 1. The tissue obtains its potential to resist higher compressive loads from the balance in between the osmotic swelling pressure of proteoglycans, highly charged macromolecules comprised of glycosaminoglycans (GAGs), along with the tension inside the collagen fibers that comprise the majority with the tissue matrix 2. Due to its avascular and aneural nature, articular cartilage possesses poor intrinsic healing capability, with localized damage towards the tissue eventually worsening to severe damage for the cartilage that is classified as osteoarthritis (OA) 3. The current “gold standard” remedy for end-stage OA is total joint arthroplasty 4, five that includes the replacement from the broken bone and cartilage with a synthetic implant. This process is extremely powerful in relieving symptoms and restoring patient quality of life, but is usually prescribed for lateaged patients to become conservative with implant durability and lifespan. As a result, for youngerCorresponding Author: Dr. Clark T. Hung Columbia University Division of Biomedical Engineering 1210 Amsterdam Avenue 351 Engineering Terrace, MC 8904 New York, NY 10027 Tel: (212) 854-6542 Fax: (212) 854-8725 [email protected] et al.Pagepatients with localized cartilage damage which has not progressed towards the whole joint, orthopaedic surgeons will employ approaches that aim to generate repair tissue (i.e., microfracture, autologous chondrocyte implantation) or to transplant wholesome cartilage for the impacted location (i.e., mosaicplasty) 6 . Though all of those approaches can reduce discomfort and restore joint motion inside the short-term ( 2 years) post-operatively, new research have discovered deteriorating clinical outcomes at longer follow-up occasions (five years postoperatively) for all tactics 91. The limitations of classic treatment motivate cartilage tissue engineering efforts to create a biological replacement cartilage as a future therapy for osteoarthritis. Such a replacement tissue would develop and remodel with the patient, broadening the age range of eligible individuals. The common paradigm for tissue engineering is usually to AAPK-25 custom synthesis combine a cell source, scaffold, and many stimuli to generate engineered tissue that replicates the in vivo properties of the native tissue 12. The majority with the cartilage engineering study performed in our laboratory utilizes major chondrocytes (freshly isolated and without the need of passaging) seeded in an agarose hydrogel scaffold. Agarose has been recognized for its well-documented capacity to market and keep the chondrocyte phenotype in long-term in vitro cultures 135. Lately, even so, clinical trials have shown the potential for agarose in cartilage regeneration, with an autologous human chondrocyte-laden ag.